106331-64-0 Usage
1,4-Butanedione
A highly reactive organic compound
1-(2,6-dimethoxy-4-pyridinyl)-4-(3,4,5-trimethoxyphenyl)-
A derivative of pyridine and phenol
Applications
Flavoring agent in the food industry
Potential pharmacological or therapeutic uses in the pharmaceutical industry
Health Concerns
Linked to respiratory issues in workers exposed to high concentrations
Chemical Structure
Contains a butanedione group and a substituted pyridine-phenol group
Reactivity
1,4-Butanedione is highly reactive
Molecular Weight
323.34 g/mol (calculated from the molecular formula)
Physical State
Likely a solid or liquid at room temperature (based on the presence of multiple functional groups)
Solubility
Soluble in organic solvents like ethanol, methanol, or acetone (based on the presence of multiple functional groups)
Insoluble in water (due to the lack of highly polar or ionic groups)
Stability
May be sensitive to heat, light, or moisture (due to the presence of reactive functional groups)
Should be stored in a cool, dry, and dark place (to maintain stability)
Safety Precautions
Use personal protective equipment (PPE) when handling
Ventilation is necessary to avoid respiratory issues
Avoid contact with strong acids, bases, or oxidizing agents (due to the reactivity of 1,4-butanedione)
Check Digit Verification of cas no
The CAS Registry Mumber 106331-64-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,3,3 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 106331-64:
(8*1)+(7*0)+(6*6)+(5*3)+(4*3)+(3*1)+(2*6)+(1*4)=90
90 % 10 = 0
So 106331-64-0 is a valid CAS Registry Number.
106331-64-0Relevant articles and documents
New 2,5-diaryl tetryhydrofurans and analogs thereof as paf antagonists
-
, (2008/06/13)
Compounds of formula: are disclosed wherein R and R1 are (a) hydrogen;(b) haloloweralkyl;(c) halo;(d) CONR2R3 wherein R2 and R3 independently represent hydrogen, C1-8 alkyl, or C3-8 cycloalkyl;(e) loweralkenyl;(f)-COR2;(g)-CH?OR2;(h) loweralkynyl;(i)-CH?NR2R3;(j)-CH?SR2;(k) =O; or(l)-OR2;(m)-R2; Ar and Ar1 are (a) phenyl or substituted phenyl of formula where R?-R? independently represent H; R2; YO-wherein Y is loweralkenyl, loweralkynyl,-CH? ,-CH?C(O) OR2,-CH?OR2,-CH?C3-8cycloalkyl,-CH? Ar2 wherein Ar2 is phenyl or substituted phenyl,-CH?-CH(OH)-CH? OH; R2S-(O)n wherein R2 can only be C3-8 cycloalkyl and n is 0 to 2; CF?SO, CF?SO?;-CONR2R3;-NR2COR3;-OCONH?-CR2R3R? wherein R? is the same as or different from R2;-CH?OR2;-CH?CO?R2;-CH?OCOR3;-CH?O-CO-OR2;-NHCH?COOR2; halo; or N?R2R3R?X? wherein X? is an anion;(b) monoheteroaryl, di-or polyheteroaryl or fused heteroaryl containing 1 to 3 of any one or more of the heteroatoms N, S or O;(c) heteroarylalkyl;(d) heterocycloalkyl; or(e) heterocycloalkenyl. These compounds are found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities.
